Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Amortizatization of Intangibles (2016)

CNBX Pharmaceuticals (CNBX) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $7127.0 as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Amortizatization of Intangibles changed N/A year-over-year to $7127.0, compared with a TTM value of $7127.0 through Feb 2017, down 44.64%, and an annual FY2016 reading of $20000.0, changed N/A over the prior year.
  • Amortizatization of Intangibles was $7127.0 for Q2 2016 at CNBX Pharmaceuticals, down from $10459.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $10459.0 in Q1 2016 and bottomed at $2414.0 in Q4 2015.